Drugs / 11C-HY-2-15
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06032026 | Jul 2023 → Jul 2028 expected | tauopathy | University of Pennsylvania | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 11C-HY-2-15 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06032026 ↗ |